Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

JNJ-38158471

Copy Product Info
😃Good
Catalog No. T22349Cas No. 951151-97-6
Alias CS-2660

JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.

JNJ-38158471

JNJ-38158471

Copy Product Info
😃Good
Purity: 97.08%
Catalog No. T22349Alias CS-2660Cas No. 951151-97-6
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$34In StockIn Stock
5 mg$75In StockIn Stock
10 mg$111In StockIn Stock
25 mg$191In StockIn Stock
50 mg$278In StockIn Stock
100 mg$375-In Stock
200 mg$515-In Stock
1 mL x 10 mM (in DMSO)$81In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.08%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

JNJ-38158471 AI Summary
JNJ-38158471 shows bioactivity as an inhibitor of various kinases, including CSF1R, VEGFR2, FLT1, FLT3, FLT4, KIT, PDGFRalpha, and RET, with varying IC50 values. It exhibits significant antitumor activity in A431, HCT116, and A375 human cancer cell xenografted mouse models. The pharmacokinetic profile demonstrates good oral bioavailability, moderate half-life, and clearance rates in BALB/c mice and rats..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
Targets&IC50
c-Kit:500 nM, RET:180 nM, VEGFR2:40 nM
SynonymsCS-2660
Chemical Properties
Molecular Weight364.79
FormulaC15H17ClN6O3
Cas No.951151-97-6
SmilesCCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N\OC)cc1Cl
Relative Density.1.42±0.1 g/cm3 (20 °C, 760 mmHg)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 30 mg/mL (82.24 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2 mg/mL (5.48 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7413 mL13.7065 mL27.4130 mL137.0652 mL
5 mM0.5483 mL2.7413 mL5.4826 mL27.4130 mL
10 mM0.2741 mL1.3707 mL2.7413 mL13.7065 mL
20 mM0.1371 mL0.6853 mL1.3707 mL6.8533 mL
50 mM0.0548 mL0.2741 mL0.5483 mL2.7413 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy JNJ-38158471 | purchase JNJ-38158471 | JNJ-38158471 cost | order JNJ-38158471 | JNJ-38158471 chemical structure | JNJ-38158471 formula | JNJ-38158471 molecular weight